Views and analysis
Nokia has completed its digital health rebirth, unveiling its first devices since acquiring Withings.
Access to new medicines is not high up the list of priorities for NHS England, but pharma must seize opportunities to promote innovation uptake.
Assessing the global challenges inhibiting immuno-oncology market access.
Complex and evolving cancer treatment pathways require comprehensive and tailored support programmes.
The factors to consider when developing medical-grade wearables.
Can Apple succeed where others can’t?
Partnerships, co-marketing and the positioning of drugs are shaping the competitive landscape in oncology.
